Kimberly Pfleeger

Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates

Q. Barraud, G. Courtine, J. Guest, 2021, Neurobiology of Disease.

Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion

Charles Tator, G. Fox, V. Nimmrich, 2023, Translational stroke research.